Increased sensitivity to the stimulant effects of morphine conferred by anti-adhesive glycoprotein SPARC in amygdala

Nat Med. 2000 Aug;6(8):910-5. doi: 10.1038/78675.

Abstract

Repeated administration of morphine substantially increases its locomotor-enhancing activity, a phenomenon termed locomotor sensitization. Here we show that secreted protein acidic and rich in cysteine (SPARC), an anti-adhesive glycoprotein present in the basolateral amygdala, contributes to the establishment of locomotor sensitization. The morphine-induced increase in SPARC levels in the basolateral amygdala persisted after morphine withdrawal and coincided with the duration of locomotor sensitization. Moreover, a single injection of morphine after SPARC infusion into the basolateral amygdala of previously uninjected mice substantially enhanced locomotor activity. Thus, SPARC may be an important element for establishing locomotor sensitization to morphine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amygdala / drug effects*
  • Amygdala / physiology
  • Animals
  • Base Sequence
  • Cell Adhesion
  • DNA Primers / genetics
  • Drug Tolerance
  • Male
  • Mice
  • Morphine / administration & dosage
  • Morphine / pharmacology*
  • Motor Activity / drug effects
  • Osteonectin / administration & dosage
  • Osteonectin / genetics
  • Osteonectin / pharmacology*
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / pharmacology
  • Substance Withdrawal Syndrome / physiopathology
  • Up-Regulation

Substances

  • DNA Primers
  • Osteonectin
  • Recombinant Fusion Proteins
  • Morphine